In a nutshell People with type 2 diabetes taking semaglutide (Ozempic/Wegovy) showed up to 46% lower dementia risk compared to those on other diabetes medications The protective effects were strongest in younger adults under 65, women, and patients with obesity While promising, this observational study cant prove the drug prevents dementiamore research through clinical trials is needed CLEVELAND For millions of Americans taking Ozempic or Wegovy, there might be more good news coming
PlexusDx recommends using a new needle for each injection and never reusing needles between doses
As your body ages, it becomes less efficient at breaking down micronutrients and delivering them where they are most needed
For people with obesity, researchers found GLP-1 users had a 65 percent lower risk of alcohol-related hospitalization than those taking AUD medications
p-eNOS, phosphorylated endothelial nitric oxide synthases
The dosage comparison chart shows equivalent doses and expected responses for both compounds
